1. Market Research
  2. > Pharmaceutical Market Trends
  3. > Hong Kong Pharmaceuticals and Healthcare Report Q2 2016

Hong Kong Pharmaceuticals and Healthcare Report Q2 2016

  • April 2016
  • -
  • Business Monitor International
  • -
  • 98 pages

Includes 3 FREE quarterly updates

Headline Expenditure Projections

- Pharmaceuticals: HKD13.0bn (USD1.7bn) in 2015 to HKD13.7bn (USD1.7bn) in 2016; +5.7% in localcurrency and 5.4% US dollars terms.

- Healthcare: HKD140.4bn (USD18.1bn) in 2015 to HKD149.7bn (USD19.3bn) in 2016; +6.7% in localcurrency and 6.4% in US dollars terms.

Table Of Contents

Hong Kong Pharmaceuticals and Healthcare Report Q2 2016
BMI Industry View 7
Table: Headline Pharmaceuticals and Healthcare Forecasts (Hong Kong 2014-2020) 7
SWOT 9
Industry Forecast 11
Pharmaceutical Market Forecast 11
Table: Pharmaceutical Sales, Historical Data And Forecasts (Hong Kong 2012-2020) 12
Healthcare Market Forecast 13
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Hong Kong 2012-2020) 15
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Hong Kong 2012-2020) 15
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Hong Kong 2012-2020) 16
Prescription Drug Market Forecast 17
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Hong Kong 2012-2020) 19
Patented Drug Market Forecast 20
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Hong Kong 2012-2020) 21
Generic Drug Market Forecast 22
Table: Generic Drug Market Indicators, Historical Data And Forecasts (Hong Kong 2012-2020) 23
OTC Medicine Forecast 24
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Hong Kong 2012-2020) 26
Pharmaceutical Trade Forecast 27
Table: Pharmaceutical Trade Data And Forecasts (Hong Kong 2014-2020) 28
Table: Pharmaceutical Trade Data And Forecasts local currency (Hong Kong 2014-2020) 29
Industry Risk/Reward Index 30
Asia Pacific Risk/Reward Index 30
Hong Kong Risk/Reward Index 36
Rewards 36
Risks 36
Regulatory Review 38
Table: Processed Applications 39
Intellectual Property Issues 41
Pricing And Reimbursement Regime 43
Table: Number Of Drugs In Drug Formulary 44
Market Overview 46
Healthcare Sector 47
Table: Healthcare Resources (Hong Kong 2010-2015) 49
Table: Healthcare Personnel (Hong Kong 2010-2015) 50
Table: Healthcare Activity (Hong Kong 2010-2015) 50
Clinical Trials 56
Table: Top Causes Of Deaths In Hong Kong 59
Competitive Landscape 60
Research-Based Industry 60
Table: Multinational Market Activity 62
Pharmaceutical Distribution 63
Pharmaceutical Retail Sector 64
Company Profile 66
Wuyi International Pharmaceutical 66
CK Life Sciences 69
GlaxoSmithKline 73
Pfizer 76
Sanofi 79
Merck and Co 82
Novartis 84
Demographic Forecast 87
Table: Population Headline Indicators (Hong Kong 1990-2025) 88
Table: Key Population Ratios (Hong Kong 1990-2025) 88
Table: Urban/Rural Population and Life Expectancy (Hong Kong 1990-2025) 89
Table: Population By Age Group (Hong Kong 1990-2025) 89
Table: Population By Age Group % (Hong Kong 1990-2025) 90
Glossary 92
Methodology 94
Pharmaceutical Expenditure Forecast Model 94
Healthcare Expenditure Forecast Model 94
Notes On Methodology 95
Risk/Reward Index Methodology 96
Index Overview 97
Table: Pharmaceutical Risk/Reward Index Indicators 97
Indicator Weightings 98

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

  • $ 10995
  • Industry report
  • September 2016
  • by Global Data

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024 Summary Attention deficit hyperactivity disorder (ADHD) is characterized by excessive levels ...

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

  • $ 7000
  • Industry report
  • August 2016
  • by Frost & Sullivan

Emerging Business Models Drive Transformation The key objective of this research is to provide in-depth knowledge of the major global pharmaceutical CMO market segments—active pharmaceutical ingredients ...

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation

  • $ 6995
  • Industry report
  • November 2016
  • by GBI Research

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation Summary Asthma is a chronic condition affecting ...


ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.